Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000255

Options or other derivatives

  • Director acquired 5,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Chavez Margarita Director 2025-06-25 Grant or award · Stock Option (Right to Buy) +5,860 5,860 D: show line 1 in the form
Loading xslF345X05/form4.xml…